KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacific Biosciences Of California (PACB) Return on Capital Employed (2016 - 2025)

Pacific Biosciences Of California (PACB) has 15 years of Return on Capital Employed data on record, last reported at 0.89% in Q3 2025.

  • For Q3 2025, Return on Capital Employed fell 60.0% year-over-year to 0.89%; the TTM value through Sep 2025 reached 0.89%, down 60.0%, while the annual FY2024 figure was 0.33%, 13.0% down from the prior year.
  • Return on Capital Employed reached 0.89% in Q3 2025 per PACB's latest filing, roughly flat from 0.88% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.1% in Q2 2021 and bottomed at 0.89% in Q3 2025.
  • Average Return on Capital Employed over 5 years is 0.3%, with a median of 0.2% recorded in 2024.
  • Peak YoY movement for Return on Capital Employed: skyrocketed 160bps in 2021, then crashed -63bps in 2025.
  • A 5-year view of Return on Capital Employed shows it stood at 0.11% in 2021, then crashed by -86bps to 0.2% in 2022, then rose by 4bps to 0.19% in 2023, then tumbled by -90bps to 0.37% in 2024, then tumbled by -141bps to 0.89% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Capital Employed were 0.89% in Q3 2025, 0.88% in Q2 2025, and 0.83% in Q1 2025.